Delivery Order SPE2DB20D1100-SPE2DB25FE6V1
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $23,421.82 on June 26, 2025, for the supply of BIKTARVY 50-200-25 mg tablets in quantities of 30 units. This is a firm fixed-price delivery order with no set-aside designation, executed through competitive procedures. The contract is set to conclude on June 27, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. BIKTARVY is an HIV treatment...
- The Defense Logistics Agency awarded a $5,213.80 delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of BIKTARVY 50-200-25 mg tablets in quantities of 30 units. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is scheduled for completion by September 4, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $3,725.92 to AmerisourceBergen Drug Corp for the supply of BIKTARVY 50-200-25 mg tablets (30-count units). This firm fixed-price delivery order, issued on August 12, 2025, represents a non-competitive set-aside and will be performed at the contractor's facility in Conshohocken, Pennsylvania, with an ultimate completion date of August 13, 2025. BIKTARVY is an antiretroviral medication used in HIV treatment, reflecting the breadth...
- The Defense Logistics Agency awarded a delivery order valued at $31,805.90 to AmerisourceBergen Drug Corp on June 2, 2025, for the supply of BIKTARVY 50-200-25 mg tablets in quantities of 30 units. This is a firm fixed price delivery order with no set-aside designation, competitively awarded under open competition. The contract is scheduled for ultimate completion on June 3, 2025, with performance occurring at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a $14.4K delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of BIKTARVY 50-200-25 mg tablets (30-count units). The contract is classified as a firm fixed price delivery order with an ultimate completion date of September 17, 2025, and carries no set-aside designation, indicating it was competitively awarded. The place of performance is AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. BIKTARVY is an...
- The Defense Logistics Agency awarded a delivery order valued at $8,727.91 to AmerisourceBergen Drug Corp for the supply of BIKTARVY 50-200-25 mg tablets in quantities of 30 units. This is a firm fixed price, competitively awarded delivery order with no set-aside designation, scheduled for completion by August 6, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. BIKTARVY is an antiretroviral medication used in HIV treatment,...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $18,825.57 for BIKTARVY 50-200-25 mg tablets (30-count units) on August 20, 2025. This firm fixed-price, non-set-aside contract represents a single delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999.99 million through December 2026. The place of performance is AmerisourceBergen's Corporate Office...
- The Defense Logistics Agency awarded a $27,168.42 firm fixed-price delivery order to AmerisourceBergen Drug Corp for BIKTARVY 50-200-25 mg tablets (30-count units) with an ultimate completion date of September 22, 2025. This non-set-aside competitive award was issued on September 19, 2025, with performance occurring at the contractor's corporate office location in Conshohocken, Pennsylvania. BIKTARVY is a prescription antiretroviral medication used in the treatment of HIV, reflecting the broad...
- The Defense Logistics Agency awarded a delivery order valued at $25,916.48 to AmerisourceBergen Drug Corp for BIKTARVY 50-200-25 mg tablets in quantities of 30 units. This firm fixed-price, non-set-aside contract was awarded on August 8, 2025, with an ultimate completion date of August 11, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. BIKTARVY is a prescription antiretroviral medication used in HIV treatment, reflecting the Defense...
- The Defense Logistics Agency awarded a delivery order valued at $7,948.35 to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of BIKTARVY 50-200-25 mg tablets in quantities of 30 units. This is a firm fixed price delivery order with no set-aside designation, competitively awarded to the prime contractor. The order is scheduled for completion by July 29, 2025, and will be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. BIKTARVY is an...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB25FE6V1Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of BIKTARVY 50-200-25 mg tablets (30-count units) valued at $23,129.73. This firm fixed-price delivery order, which is not set-aside, is scheduled for completion by September 16, 2025, and will be fulfilled from the contractor's location in Conshohocken, Pennsylvania. BIKTARVY is an antiretroviral medication used in HIV treatment, representing the type of specialized pharmaceutical products that AmerisourceBergen supplies through its federal medical procurement contracts. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. As a major pharmaceutical distributor, AmerisourceBergen leverages this comprehensive global contract vehicle to supply a broad range of medications, vaccines, and medical supplies to support military healthcare programs and other federal health systems. The company's consistent performance across competitively awarded delivery orders demonstrates its capability to fulfill critical medical supply requirements for the Department of Defense and related federal agencies.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $23.1k | 9/15/25 |